These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31536762)

  • 1. aQbD as a platform for IVRT method development - A regulatory oriented approach.
    Miranda M; Pais AACC; Cardoso C; Vitorino C
    Int J Pharm; 2019 Dec; 572():118695. PubMed ID: 31536762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
    Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
    Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2018 Jan; 535(1-2):217-227. PubMed ID: 28935255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams.
    Wellington H; Rath S; Kanfer I
    Eur J Pharm Sci; 2024 Jan; 192():106649. PubMed ID: 37992910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and optimisation of Ozenoxacin topical nano-emulgel including a comprehensive methodology to qualify and validate the critical parameters of an
    Ramireddy AR; Behara DK
    Drug Dev Ind Pharm; 2024 Apr; 50(4):320-330. PubMed ID: 38459688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical bioequivalence: Experimental and regulatory considerations following formulation complexity.
    Miranda M; Veloso C; Brown M; C Pais AAC; Cardoso C; Vitorino C
    Int J Pharm; 2022 May; 620():121705. PubMed ID: 35358644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diving into Batch-to-Batch Variability of Topical Products-a Regulatory Bottleneck.
    Miranda M; Cova T; Augusto C; Pais AACC; Cardoso C; Vitorino C
    Pharm Res; 2020 Oct; 37(11):218. PubMed ID: 33037479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an emulgel for the treatment of rosacea using quality by design approach.
    Torregrosa A; Ochoa-Andrade AT; Parente ME; Vidarte A; Guarinoni G; Savio E
    Drug Dev Ind Pharm; 2020 Feb; 46(2):296-308. PubMed ID: 31944126
    [No Abstract]   [Full Text] [Related]  

  • 9. Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation.
    Chiarentin L; Cardoso C; Miranda M; Vitorino C
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Quality by Design (AQbD) Approach to the Development of In Vitro Release Test for Topical Hydrogel.
    Szoleczky R; Budai-Szűcs M; Csányi E; Berkó S; Tonka-Nagy P; Csóka I; Kovács A
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analytical Target Profile for the Development of an In Vitro Release Test Method and Apparatus Selection in the Case of Semisolid Topical Formulations.
    Szoleczky R; Kovács A; Berkó S; Budai-Szűcs M
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoemulsion-based gel formulation of diclofenac diethylamine: design, optimization, rheological behavior and in vitro diffusion studies.
    Hamed R; Basil M; AlBaraghthi T; Sunoqrot S; Tarawneh O
    Pharm Dev Technol; 2016 Dec; 21(8):980-989. PubMed ID: 26369621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release test (IVRT): Principles and applications.
    Shah VP; Simona Miron D; Ștefan Rădulescu F; Cardot JM; Maibach HI
    Int J Pharm; 2022 Oct; 626():122159. PubMed ID: 36067919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gellan gum fluid gels for topical administration of diclofenac.
    Mahdi MH; Conway BR; Mills T; Smith AM
    Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Quality by Design: Development to Manufacturing of Diclofenac Sodium Topical Gel.
    Khanolkar A; Thorat V; Raut P; Samanta G
    AAPS PharmSciTech; 2017 Oct; 18(7):2754-2763. PubMed ID: 28353174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drilling into "Quality by Design" Approach for Analytical Methods.
    Chiarentin L; Gonçalves C; Augusto C; Miranda M; Cardoso C; Vitorino C
    Crit Rev Anal Chem; 2023 Sep; ():1-42. PubMed ID: 37665603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Accelerated Rotator-based Drug Release Method for the Evaluation of Bupivacaine Multivesicular Liposomes.
    Xia Z; Yu M; Liu Y; Yuan W; Wang Y; Xu X; Bae J; Schwendeman A
    Pharm Res; 2024 Feb; 41(2):293-303. PubMed ID: 38212593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting in vitro release test for topical gel formulations: The effect of osmotic pressure explored for better bio-relevance.
    Jeong S; Jeong S; Chung S; Kim A
    Eur J Pharm Sci; 2018 Jan; 112():102-111. PubMed ID: 29133242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of different test parameters on in vitro drug release from topical diclofenac formulations in a vertical diffusion cell setup.
    Klein S
    Pharmazie; 2013 Jul; 68(7):565-71. PubMed ID: 23923638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
    Eichner A; Mrestani Y; Hukauf M; Wohlrab J
    Dermatol Ther (Heidelb); 2024 Jul; ():. PubMed ID: 38997617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.